Literature DB >> 2951644

Immune complex glomerulonephritis in experimental kala-azar.

A Sartori, A V De Oliveira, M C Roque-Barreira, M A Rossi, A Campos-Neto.   

Abstract

In the present work we demonstrate that hamsters infected with L. donovani eliminate large quantities of immunoglobulins in the urine. This alteration is clearly a consequence of a conspicuous immune complex glomerulonephritis readily detectable 7 days after the beginning of infection. L. donovani antigens and hamsters immunoglobulins (Igs) were revealed as granular deposits in the mesangial areas and contiguous loops of the glomeruli. Histopathological alterations such as focal mesangial proliferation with progression to diffuse proliferation were observed in the first 3 weeks of infection. From day 35 onwards, all diseased animals presented large deposits of amyloid material of predominantly glomerular localization. In consonance with these alterations, Igs were detected in the urine by day 21 of infection and their concentration increased substantially with the progression of disease. In contrast, serum Igs increased until day 21, when their concentration dropped steadily.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2951644     DOI: 10.1111/j.1365-3024.1987.tb00491.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  10 in total

1.  Immune complex glomerulonephritis in experimental kala-azar. II: Detection and characterization of parasite antigens and antibodies eluted from kidneys of Leishmania donovani-infected hamsters.

Authors:  A Sartori; M C Roque-Barreira; J Coe; A Campos-Neto
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

2.  Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis.

Authors:  M Soto; J M Requena; L Quijada; M J Perez; C G Nieto; F Guzman; M E Patarroyo; C Alonso
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

3.  Transforming growth factor beta and immunosuppression in experimental visceral leishmaniasis.

Authors:  V Rodrigues; J Santana da Silva; A Campos-Neto
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

4.  An immunohistochemical study in cases with usual and unusual clinicopathological findings of canine visceral leishmaniosis.

Authors:  Nihat Toplu; Ahmet Aydogan
Journal:  Parasitol Res       Date:  2011-04-09       Impact factor: 2.289

5.  The hamster (Mesocricetus auratus) as an experimental model of toxocariasis: histopathological, immunohistochemical, and immunoelectron microscopic findings.

Authors:  Ana Maria Gonçalves da Silva; Pedro Paulo Chieffi; Wellington Luiz Ferreira da Silva; Edite Hatsumi Yamashiro Kanashiro; Guita Rubinsky-Elefant; Edécio Cunha-Neto; Eliane Conti Mairena; Thales De Brito
Journal:  Parasitol Res       Date:  2014-12-19       Impact factor: 2.289

6.  Identification of leishmanial antigens in the sera of patients with American visceral leishmaniasis.

Authors:  T G Evans; R D Pearson
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

7.  Detection of anti-Leishmania immunoglobulin G antibodies in urine specimens of dogs with leishmaniasis.

Authors:  L Solano-Gallego; A Rodríguez; L Iniesta; M Arboix; M Portús; J Alberola
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

Review 8.  Mechanisms of resistance and susceptibility to experimental visceral leishmaniosis: BALB/c mouse versus Syrian hamster model.

Authors:  Ana Nieto; Gustavo Domínguez-Bernal; José A Orden; Ricardo De La Fuente; Nadia Madrid-Elena; Javier Carrión
Journal:  Vet Res       Date:  2011-02-23       Impact factor: 3.683

Review 9.  Renal involvement in leishmaniasis: a review of the literature.

Authors:  Anna Clementi; Giorgio Battaglia; Matteo Floris; Pietro Castellino; Claudio Ronco; Dinna N Cruz
Journal:  NDT Plus       Date:  2011-03-21

10.  Microalbuminuria and glomerular filtration rate in paediatric visceral leishmaniasis.

Authors:  Neena Verma; Chandra Shekhar Lal; Vidyanand Rabidas; Krishna Pandey; Dharmendra Singh; Sanjay Kumar; Rakesh Bihari Verma; Pradeep Das
Journal:  Biomed Res Int       Date:  2013-06-23       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.